BostonGene Wins 2025 Frost & Sullivan Award for AI Oncology Innovation
BostonGene’s comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development risk and advance precision oncology across all stages the R&D continuum Frost & Sullivan has named BostonGene the recipient of the 2025 North American Enabling Technology Leadership Award in recognition of the company’s pioneering role in advancing precision oncology. BostonGene’s clinically validated, AI-powered platform uses a multimodal approach to decode disease and uncover predictive biological…
